NCT00456144View on ClinicalTrials.gov

Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Prostate Cancer
Interventions
DRUG

Gonadotropin Releasing Hormone Agonist Therapy

Given either for 24 months and 6 months

Trial Locations (1)

02215

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00456144 - Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer | Biotech Hunter | Biotech Hunter